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To the Editor: The recent review of baroreflex failure was
timely and excellent.1 However, there were some atypical
clinical features in the described patient that might profitably
be considered.
The baroreflexes maintain blood pressure (BP) homeo-
stasis. Baroreflexes can fail in three circumstances, namely:
(1) failure of afferent signaling because of damage to the
baroreceptor, such as in the carotid sinus (BRF); (2)
problems with central processing; or (3) damage to
sympathetic and parasympathetic nerves (autonomic failure
(AF)), which are the effector arms of the reflex.2
Patients with BRF have more changes in BP, typically in
response to central stimulation (pain or emotions). In contrast,
patients with AF typically have significant BP changes due to
body position—often with severe supine hypertension and
marked orthostatic hypotension,3 as in this case. We cannot
know whether the patient’s ‘labile BP’ during ambulatory
monitoring results from the changes in the patient body
position or purely because of central stimulation.
The cold pressor test induced hypotension in this patient,
the opposite of what would be expected in BRF. One possible
explanation is that the patient is hyperventilated in response
to cold-induced pain. Patients with AF often become acutely
hypotensive in response to hyperventilation (Figure 1),
probably through a hypocarbia-induced peripheral vasodila-
tion,4 although this cannot explain the decreased heart rate.
The importance of this distinction between afferent BRF
and efferent AF is that treatments may be different. Although
central sympatholytics and anxiolytics would be therapeutic
in BRF, AF often responds better to short-acting pressors (for
hypotension) and vasodilators.
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We thank Raj and coworkers for their comments1 and how
they may apply to the patient whom we described in our
‘Renal Consult’.2
As to the issue of autonomic failure (AF), we have little
evidence of its presence in our patient. His orthostatic
blood pressure (BP) change in 19 outpatient visits to our
clinic, during the 43 months of follow-up, averaged
9/4±11/3 mm Hg. In only four instances did his BP drop
by 420/10 mm Hg upon standing, all related to poorly
tolerated treatments or intercurrent illnesses. Further-
more, his sleep BP was lower than awake BP levels on all
three ambulatory BP recordings performed. This is in
marked contrast to patients with AF who often have supine
hypertension and a reversal of the normal day/night BP
rhythm.3 Therefore, despite the limitation that our BP
recordings were not coupled to position sensors (or a
detailed diary), we have little reason to believe that his BP
liability was due to positional changes in the setting of AF.
We found intriguing the suggested explanation for his
paradoxical BP fall during the cold pressor test as due to
hyperventilation. We had not entertained it, as we never
thought our patient had AF. Despite this belief, we invited
our patient to return for retesting of his pressor responses
on 26 August 2008. His BP and heart rate responses to
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Figure 1 | Hyperventilation in a patient with autonomic
failure. Heart rate, respirations, and blood pressure (BP) are
shown before, during, and after a 30-s episode of
hyperventilation. In this example, the BP decreases (17 mm Hg in
systolic BP) with sustained hyperventilation.
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different maneuvers are described in Table 1. As he no longer
exhibited the previously observed BP fall with pressor
stimulation, we did not feel compelled to draw arterial blood
gas samples. Of note, his respiratory rate was unchanged,
though we did not measure his tidal volume.
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To the Editor: The article by Hedayati et al.1 is relevant in
that it addresses the important but underrecognized problem
of depression in the dialysis population. The goal of the study
was to investigate whether an association exists between
physician-diagnosed depression and poor outcomes. The
paper underscored the high prevalence of depression in this
population and illustrated the significant morbidity and
mortality associated with the combined diagnosis of depres-
sion and dialysis.
The authors did a good job of addressing most of the
clinical characteristics that could affect the outcome of
hospitalizations and mortality. However, phosphorus and
calcium, two clinical characteristics associated with mortality
outcomes in the dialysis population were not addressed.
The inclusion of phosphorus and calcium is highly
important in the analysis, as these biochemical markers are
associated with the outcome.2 Phosphorus in particular
should have been evaluated, as it is more difficult for the
observer to control relative to parathyroid hormone and
calcium and is dependent on the behavior of the subject, in
regard to both dietary discretion and adherence to binder
therapy. Depression by definition influences behavior; it is
essential to know if the difference in mortality between the
two patient groups can be attributed at least in part to a
difference in phosphorus and or calcium.
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The letter by Brown1 appropriately highlights the significance
of calcium and phosphorus as predictors of poor outcomes in
end-stage renal disease patients on chronic dialysis, and
inquires why these variables were not included in the
multivariable model for outcomes in our study. We recognize
that previous observational studies have shown a correlation
between phosphorus and calcium-phosphorus product and
death in this patient population.2 Earlier studies have also
shown a direct relationship between depressive symptoms
and non-adherence to diet and interdialytic weight gain in
chronic hemodialysis patients, although to our knowledge, no
published data exist to show an association between higher
phosphorus, in particular, and presence of depression.3,4 It is
also known that decreased behavioral adherence is in turn
associated with decreased survival.4
In our study, mean calcium, phosphorus, and para-
thyroid hormone levels were not significantly different
among depressed vs non-depressed patients. The baseline












Cold pressor (30 s)
Baseline 132/60 78
End 160/78 88
All tests performed in the supine position. They are reported above in the order they
were performed. 5 min of rest separated each maneuver from the next.
aValues reflect the average of three readings at each point of measurement.
bMental stress: serial 7s counted down from 300.
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